Tauroursodeoxycholic acid for treatment of primary biliary cirrhosis. A dose-response study.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/8674405
Conclusion of this study
In conclusion, a dose of about 10mg/kg body wt/day of tauroursodeoxycholic acid should be used for long-term studies in patients with primary biliary cirrhosis.
Supplements analyzed in this study
|
Health conditions analyzed in this study
No health conditions information for this study.Functions related to this study
|
||
|
||
|
||
|
Body systems related to this study
 Cardiovascular System |
 Digestive System |
